First Patient Dosed in ALS Gene-Targeting Trial Using Sphingolipid Therapy
Leal Therapeutics launches first-in-human trial of LTX-002, an antisense drug targeting toxic lipid buildup in ALS motor neurons.
4,593 articles in this topic
Leal Therapeutics launches first-in-human trial of LTX-002, an antisense drug targeting toxic lipid buildup in ALS motor neurons.
NorthStrive Biosciences files patents targeting muscle loss — a major side effect of GLP-1 obesity drugs — using peptide and microbiome tech.
A newly identified lncRNA found only in primates accelerates cellular senescence and aging-like decline via a novel RNA-protein pathway.
AGEs silently degrade collagen and elastin, accelerating wrinkles and laxity. New diagnostics and therapies are emerging to fight back.
A novel nanoparticle combining NAC antioxidant capping with the neuropeptide TLQP21 reverses depression-like behavior in stressed mice.
A newly identified mitochondrial pathway protects alveolar stem cells from oxidative stress, cutting fibrosis and inflammation in mouse lung injury models.
Scientists discover a bacterial weapon structurally identical to human CD38 that drains NAD+ — a molecule central to aging and cellular energy.
A new review outlines how diet, movement, supplements, and hormone therapy combine to ease perimenopause and support long-term healthy aging.
New review reveals the perimenopause window is when metabolic, cardiovascular, and bone health shift most dramatically — not after.
A natural flavonoid found in fruits clears senescent cells and restores artery function damaged by doxorubicin chemotherapy in mice.
Mesenchymal stem cells and their exosomes show strong promise for repairing endometrial damage caused by intrauterine adhesions and endometriosis.
A 2025 review evaluates autologous HSC transplantation and mesenchymal stem cells as transformative treatments for systemic sclerosis.